Fig. 2From: Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lungReceiver operating characteristic (ROC) curve for lung adenocarcinoma (LAC) and benign samples. The ROC curve was based on 20% LAC samples and 20% of benign samples visualizing the discriminatory model obtained with single proteins CXCL17, CEACAM5, ERBB3, VEGFR2 and the combination of all four proteinsBack to article page